课题基金 / 基金详情

Involovement of p16 tumor suppressor gene in cell cycle progression

Involovement of p16 tumor suppressor gene in cell cycle progression
p16 抑癌基因参与细胞周期进程
批准号:
07671773
负责人:
YOKOYAMA Yasuhiro
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

YOKOYAMA Yasuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
我们首先研究了宫颈上皮样癌细胞HeLa细胞、子宫内膜癌细胞Ishikawa细胞和卵巢上皮性癌细胞2780细胞中p21和p16的表达。三种细胞株均稳定表达p21和p16的mRNA和蛋白。然而,这些细胞系的表达水平相对较弱。P21和p16的序列分析表明,所有细胞株的p16和p21均为野生型,而Ishikawa细胞的p21mRNA密码子31为精氨酸多态。其次,对2780株P53基因进行了序列分析,发现其密码子178缺失。HeLa细胞的P53蛋白被18型乳头瘤病毒E6蛋白灭活,因此我们推测这些细胞系中的p21不依赖于P53,p21基因转移到这两个细胞系中可能是有意义的。我们将p21基因亚克隆到真核表达载体pMAMneo和逆转录病毒载体pXT1中,并将其导入这些细胞系。经G418筛选,获得HeLa和2780细胞亚系。这些亚系表现出明显的细胞生长迟缓和端粒酶活性减弱。用流式细胞仪进行细胞周期分析表明,G0G1到S的阻滞是细胞生长迟缓的主要原因。这些结果表明,将p21基因导入p53被病毒癌蛋白灭活的癌细胞,将比p53本身更有效地抑制细胞生长。
英文摘要
We first studies the expression of p21 and p16 in HeLa cell, a epidermoid carcinoma cells of the cervix, Ishikawa cell, a endometrial carcinoma cells, and 2780 cell, an ovarian epithelial carcinoma cell. All three cell lines steadily express mRNA and protein of p21 and p16. The expression levels of these cell lines, however, were relatively weak. Sequence analysis of p21 and p16 of these cell lines revealed that p16 and p21 of all cell line were wild types, though codon 31 of p21 mRNA of Ishikawa cell was arginine polymorphism. Next, p53 gene of 2780 was studied by using sequence analysis, showing deletion in its codon 178. The p53 of HeLA cells is inactivated by E6 protein of papilloma virus type 18. Therefore we supposed that p21 of these cell lines was independent of p53 and gene transfer of p21 into these two cell line may make a sense. We subcloned p21 gene into pMAMneo, a eucaryotic expression vector and pXT1 a retroviral vector and introduced into these cell lines. After G418 selection, we obtained sublines of HeLa and 2780 cells. These sublines showed apparent retardation of cell growth and attenuated telomerase activity. Cell cycle analysis using flowcytometry showed that the blockage from G0G1 to S is major cause of cell growth retardation. These results suggest that introduction of p21 gene into carcinoma cells of which p53 is inactivated by viral oncoproteins will suppress cell growth more efficiently than p53 itself.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokoyama Y.et al.: "Immunohistochemical study of estradiol, epidermal growth factor, transfeorming growth factor alpha and epidermal growth factor receptor." Jpn.J.Clin.Oncol. 26. 411-416 (1997)
Yokoyama Y.等人:“雌二醇、表皮生长因子、转化生长因子α和表皮生长因子受体的免疫组织化学研究。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
高橋雄一郎: "サイクリンインヒビターを用いた遺伝子治療に関する基礎的検討" 日本癌学会総会記事. 188-188 (1995)
Yuichiro Takahashi:“使用细胞周期蛋白抑制剂进行基因治疗的基础研究”,日本癌症协会大会上的文章188-188(1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Involvement of PTEN in hormone-dependent proliferation of endometrial ocarcinoma cells
    • 批准号:
      14571552
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      YOKOYAMA Yasuhiro
    • 依托单位:
    Gene therapy with hammerhead ribozymes targeting telomerase components in the endometrial carcinoma.
    • 批准号:
      10671528
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.15万
    • 财政年份:
      1998
    • 负责人:
      YOKOYAMA Yasuhiro
    • 依托单位:
    国内基金
    海外基金
    靶向调控Bmi-1/P16Ink4α信号途径介导喉癌细胞高增殖亚群早熟衰老及化疗增敏的实验研究
    • 批准号:
      30973288
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2009
    • 负责人:
      金春顺
    • 依托单位:
    P16INK4和P15INK4B与人原发性肝癌的演变与逆转研究
    • 批准号:
      39670702
    • 项目类别:
      面上项目
    • 资助金额:
      10.0万元
    • 批准年份:
      1996
    • 负责人:
      覃扬
    • 依托单位:
    CDKN2基因突变对P16INK4蛋白功能的影响